Early research (Phase 1)Ended earlyNCT04609943
What this trial is testing
Study to Find the Highest Safe Dose of Soluble Guanylate Cyclase (sGC) Activator, BAY 1211163 Administered as Multiple Doses by Inhalation to Patients Who Cannot Breathe by Their Own and Suffer From a Type of Lung Failure That Causes Fluid to Build up in the Lungs Making Breathing Difficult (ARDS)
Who this might be right for
Acute Respiratory Distress Syndrome
Bayer 16